September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News

September 03, 2025

FDA Approves Denosumab Biosimilars

The FDA approved Bildyos and Bilprevda are providing new options comparable to Prolia and Xgeva for osteoporosis, cancer-related bone disease, and other skeletal conditions.

Conexiant

August 28, 2025

Late Dinners, Fragile Bones?

Fracture risk varies by site, with distal forearm outcomes diverging from hip, vertebral, and humeral patterns

Conexiant

August 26, 2025

Ancient Bones Tell Tales

Perhaps so-called modern diseases aren’t as new as we thought...

The Pathologist

August 22, 2025

New Recommendations Released for Managing Aromatase Inhibitor–Induced Bone Loss

A group of experts from seven professional societies have published a joint position statement in the Journal of Bone Oncology on the management of aromatase inhibitor–associated bone loss as a guide ...

The ASCO Post

August 20, 2025

USO Tied to Lower HGSC Risk, Study Shows

Researchers assess whether unilateral salpingo-oophorectomy before age 50 lowers cancer risk without raising cardiovascular or bone complications.

Conexiant

August 18, 2025

Health Groups Respond to 'National Scandal'

With elder homelessness rising, PACE programs funded by Medicaid and Medicare secure housing and health care for low-income seniors, seen in Rhode Island.

KFF Health News

November 18, 2024

Leptin's Role in Energy Deficiency Syndromes

Researchers present new insights into Relative Energy Deficiency in Sport, emphasizing its impact on athletes and military personnel, and discussing potential prevention and treatment strategies.

Conexiant

December 10, 2024

Hormone Therapy Risks Vary: Tibolone Linked to Arterial Events

Recent study links tibolone use in menopausal hormone therapy to a 52% increased cardiovascular disease risk, emphasizing the need for tailored hormone therapy approaches and further research in BMJ.

Conexiant